53.03 USD
+0.92 (+1.77%)
53.03 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to SOLS. SOLS was compared to 83 industry peers in the Chemicals industry. While SOLS has a great profitability rating, there are quite some concerns on its financial health. SOLS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
SOLS had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: SOLS reported negative net income in multiple years.
In multiple years SOLS reported negative operating cash flow during the last 5 years.
1.2 Ratios
SOLS's Return On Assets of 11.32% is amongst the best of the industry. SOLS outperforms 96.39% of its industry peers.
With an excellent Return On Equity value of 18.40%, SOLS belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
SOLS has a Return On Invested Capital of 15.55%. This is amongst the best in the industry. SOLS outperforms 95.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SOLS is significantly above the industry average of 6.10%.
The 3 year average ROIC (19277.20%) for SOLS is well above the current ROIC(15.55%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.32% | ||
| ROE | 18.4% | ||
| ROIC | 15.55% |
ROA(3y)7294.93%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19277.2%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 15.76%, SOLS belongs to the top of the industry, outperforming 95.18% of the companies in the same industry.
SOLS has a better Operating Margin (21.83%) than 89.16% of its industry peers.
SOLS has a Gross Margin of 34.64%. This is in the better half of the industry: SOLS outperforms 69.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.83% | ||
| PM (TTM) | 15.76% | ||
| GM | 34.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SOLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SOLS has about the same amount of shares outstanding.
The number of shares outstanding for SOLS has been increased compared to 5 years ago.
The debt/assets ratio for SOLS is higher compared to a year ago.
2.2 Solvency
A Debt/Equity ratio of 0.13 indicates that SOLS is not too dependend on debt financing.
SOLS's Debt to Equity ratio of 0.13 is amongst the best of the industry. SOLS outperforms 86.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACC1.01
WACC15.43%
2.3 Liquidity
SOLS has a Current Ratio of 1.53. This is a normal value and indicates that SOLS is financially healthy and should not expect problems in meeting its short term obligations.
SOLS has a Current ratio of 1.53. This is in the lower half of the industry: SOLS underperforms 69.88% of its industry peers.
A Quick Ratio of 0.93 indicates that SOLS may have some problems paying its short term obligations.
SOLS has a Quick ratio of 0.93. This is in the lower half of the industry: SOLS underperforms 63.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
SOLS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.35%.
Looking at the last year, SOLS shows a small growth in Revenue. The Revenue has grown by 3.32% in the last year.
The Revenue has been growing by 2650.90% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)3.32%
Revenue growth 3Y2650.9%
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to decrease by -4.38% on average over the next years.
The Revenue is expected to grow by 3.73% on average over the next years.
EPS Next Y-45.83%
EPS Next 2Y-11.59%
EPS Next 3Y-4.38%
EPS Next 5YN/A
Revenue Next Year3.34%
Revenue Next 2Y3.51%
Revenue Next 3Y3.73%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.18, which indicates a correct valuation of SOLS.
Based on the Price/Earnings ratio, SOLS is valued a bit cheaper than 73.49% of the companies in the same industry.
SOLS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.00.
The Price/Forward Earnings ratio is 18.13, which indicates a rather expensive current valuation of SOLS.
SOLS's Price/Forward Earnings ratio is in line with the industry average.
SOLS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.18 | ||
| Fwd PE | 18.13 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SOLS is valued a bit cheaper than the industry average as 73.49% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.97 |
4.3 Compensation for Growth
The decent profitability rating of SOLS may justify a higher PE ratio.
SOLS's earnings are expected to decrease with -4.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.59%
EPS Next 3Y-4.38%
5. Dividend
5.1 Amount
SOLS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
53.03
+0.92 (+1.77%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners25.13%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change-5205870%
Market Cap8.42B
Revenue(TTM)3.77B
Net Income(TTM)594.00M
Analysts76
Price Target58.96 (11.18%)
Short Float %1.83%
Short Ratio1.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.2%
PT rev (3m)N/A
EPS NQ rev (1m)-3.31%
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.28%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.18 | ||
| Fwd PE | 18.13 | ||
| P/S | 2.23 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.61 | ||
| P/tB | 3.55 | ||
| EV/EBITDA | 7.97 |
EPS(TTM)3.74
EY7.05%
EPS(NY)2.93
Fwd EY5.52%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS23.75
BVpS20.34
TBVpS14.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number41.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.32% | ||
| ROE | 18.4% | ||
| ROCE | 20.47% | ||
| ROIC | 15.55% | ||
| ROICexc | 17.35% | ||
| ROICexgc | 22.78% | ||
| OM | 21.83% | ||
| PM (TTM) | 15.76% | ||
| GM | 34.64% | ||
| FCFM | N/A |
ROA(3y)7294.93%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19277.2%
ROIC(5y)N/A
ROICexc(3y)54278.7%
ROICexc(5y)N/A
ROICexgc(3y)54283.9%
ROICexgc(5y)N/A
ROCE(3y)-199689%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC15.43%
ROIC/WACC1.01
Cap/Depr(3y)145.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.71%
Cap/Sales(5y)N/A
Profit Quality(3y)78.83%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-45.83%
EPS Next 2Y-11.59%
EPS Next 3Y-4.38%
EPS Next 5YN/A
Revenue 1Y (TTM)3.32%
Revenue growth 3Y2650.9%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.34%
Revenue Next 2Y3.51%
Revenue Next 3Y3.73%
Revenue Next 5YN/A
EBIT growth 1Y0%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.85%
EBIT Next 3Y10.68%
EBIT Next 5YN/A
FCF growth 1Y18.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.79%
OCF growth 3YN/A
OCF growth 5YN/A
SOLSTICE ADV MATERIALS INC / SOLS FAQ
What is the fundamental rating for SOLS stock?
ChartMill assigns a fundamental rating of 4 / 10 to SOLS.
What is the valuation status of SOLSTICE ADV MATERIALS INC (SOLS) stock?
ChartMill assigns a valuation rating of 3 / 10 to SOLSTICE ADV MATERIALS INC (SOLS). This can be considered as Overvalued.
How profitable is SOLSTICE ADV MATERIALS INC (SOLS) stock?
SOLSTICE ADV MATERIALS INC (SOLS) has a profitability rating of 7 / 10.
How financially healthy is SOLSTICE ADV MATERIALS INC?
The financial health rating of SOLSTICE ADV MATERIALS INC (SOLS) is 3 / 10.
What is the expected EPS growth for SOLSTICE ADV MATERIALS INC (SOLS) stock?
The Earnings per Share (EPS) of SOLSTICE ADV MATERIALS INC (SOLS) is expected to decline by -45.83% in the next year.